Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sapphire Innovative Therapies is a private North Carolina company operating in healthcare nutrition rather than traditional drug development. Public business-directory and trademark records indicate that the company markets products under the Nutraheal name and is focused on dietary or nutritional supplements intended to support wound healing and recovery. Available evidence suggests it is a small, active LLC rather than a clinical-stage biotech, pharma, or therapeutics developer. No verified clinical pipeline, drug targets, or pharmaceutical development programs were identified in public sources reviewed. The company appears best characterized as a commercial-stage medical nutrition or nutraceutical business focused on wound-care support products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sapphire Innovative Therapies.